N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance

L H Jensen1, I Wessel, M Møller

  • 1Department of Pathology, Laboratory Center, Righospitalet, Copenhagen, Denmark. lhjensen@rh.dk

FEBS Letters
|October 18, 2000
PubMed

Insights

Mutations in human topoisomerase II alpha can confer resistance to bisdioxopiperazine compounds like ICRF-187. These mutations affect drug response through different mechanisms, highlighting distinct protein domains involved.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Human topoisomerase II alpha is a crucial enzyme for DNA replication and repair.
  • Bisdioxopiperazine compounds, such as ICRF-187, are known inhibitors of topoisomerase II.
  • Understanding drug resistance mechanisms is vital for developing effective cancer therapies.

Purpose of the Study:

  • To identify mutations in human topoisomerase II alpha that confer resistance to ICRF-187.
  • To investigate the mechanisms underlying cellular bisdioxopiperazine resistance.
  • To explore the role of different protein domains in drug response.

Main Methods:

  • Random mutagenesis of human topoisomerase II alpha cDNA.
  • Functional expression in yeast cells lacking endogenous topoisomerase II activity.
  • Clonogenic assays to measure cellular resistance to ICRF-187.
  • In vitro assays with purified recombinant mutant proteins to assess catalytic inhibition.

Main Results:

  • Five functional mutations (L169F, G551S, P592L, D645N, T996L) conferring significant ICRF-187 resistance were identified.
  • The L169F mutation resulted in a protein highly resistant to ICRF-187 inhibition in vitro.
  • Mutations G551S, D645N, and T996L conferred cellular resistance without affecting in vitro catalytic sensitivity.
  • Results suggest at least two distinct classes of mutations conferring bisdioxopiperazine resistance.

Conclusions:

  • Cellular resistance to bisdioxopiperazines can arise from mutations that either alter drug interaction or affect other cellular processes.
  • Different domains within topoisomerase II alpha are involved in mediating the response to bisdioxopiperazine compounds.
  • These findings provide insights into drug resistance mechanisms and potential therapeutic strategies targeting topoisomerase II.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...